Cytokinetics, Incorporated (CYTK) Social Stream
CYTOKINETICS INC (CYTK) Price Targets From Analysts
Use the tables below to see what analysts covering CYTOKINETICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $75 | $40 | $53.444 | $33.46 | 59.73% |
| 2021-12-01 | 9 | $75 | $40 | $53.5 | $33.46 | 59.89% |
| 2021-12-10 | 10 | $75 | $40 | $53.909 | $33.46 | 61.11% |
| 2021-12-21 | 10 | $75 | $40 | $54.545 | $33.46 | 63.02% |
| 2022-02-01 | 11 | $75 | $40 | $54.666 | $33.46 | 63.38% |
| 2022-02-15 | 11 | $75 | $40 | $54.5 | $33.46 | 62.88% |
| 2022-02-28 | 11 | $75 | $40 | $54.166 | $33.46 | 61.88% |
| 2022-03-02 | 11 | $75 | $40 | $53.916 | $33.46 | 61.14% |
| 2022-04-13 | 11 | $75 | $40 | $54.272 | $33.46 | 62.2% |
| 2022-04-29 | 11 | $75 | $40 | $55.181 | $33.46 | 64.92% |
| 2022-05-05 | 11 | $75 | $40 | $55.636 | $33.46 | 66.28% |
| 2022-05-16 | 11 | $75 | $40 | $57.545 | $33.46 | 71.98% |
| 2022-05-23 | 12 | $80 | $40 | $60.916 | $33.46 | 82.06% |
| 2022-05-26 | 12 | $80 | $40 | $59.5 | $33.46 | 77.82% |
| 2022-06-17 | 12 | $80 | $40 | $61.333 | $33.46 | 83.3% |
| 2022-08-05 | 10 | $80 | $54 | $64.545 | $33.46 | 92.9% |
| 2022-08-09 | 10 | $80 | $56 | $65.636 | $33.46 | 96.16% |
| 2022-08-12 | 10 | $80 | $15 | $61.545 | $33.46 | 83.94% |
| 2022-09-02 | 10 | $80 | $15 | $62.727 | $33.46 | 87.47% |
| 2022-10-03 | 11 | $82 | $15 | $64.333 | $33.46 | 92.27% |
| 2022-11-03 | 12 | $82 | $15 | $65.538 | $33.46 | 95.87% |
| 2022-11-20 | 12 | $82 | $57 | $69 | $33.46 | 106.22% |
| 2022-12-09 | 12 | $82 | $55 | $68.307 | $33.46 | 104.15% |
| 2022-12-14 | 12 | $82 | $55 | $67.923 | $33.46 | 103% |
| 2022-12-15 | 12 | $82 | $55 | $66.461 | $33.46 | 98.63% |
| 2022-12-20 | 13 | $82 | $55 | $65 | $33.46 | 94.26% |
| 2022-12-23 | 14 | $82 | $55 | $64.857 | $33.46 | 93.83% |
| 2023-02-14 | 14 | $80 | $47 | $62.357 | $33.46 | 86.36% |
| 2023-02-21 | 15 | $80 | $47 | $61.466 | $33.46 | 83.7% |
| 2023-03-01 | 15 | $80 | $47 | $61.4 | $33.46 | 83.5% |
| 2023-03-02 | 15 | $80 | $48 | $61.533 | $33.46 | 83.9% |
| 2023-03-06 | 15 | $80 | $48 | $61.933 | $33.46 | 85.1% |
| 2023-03-07 | 15 | $80 | $48 | $61.933 | $33.46 | 85.1% |
| 2023-03-20 | 15 | $80 | $48 | $61.733 | $33.46 | 84.5% |
| 2023-03-31 | 15 | $80 | $42 | $61.2 | $33.46 | 82.9% |
| 2023-04-03 | 15 | $80 | $42 | $60.533 | $33.46 | 80.91% |
| 2023-04-18 | 15 | $80 | $42 | $60.2 | $33.46 | 79.92% |
| 2023-05-05 | 15 | $80 | $41 | $60.466 | $33.46 | 80.71% |
| 2023-06-06 | 15 | $80 | $41 | $60.533 | $33.46 | 80.91% |
| 2023-08-07 | 16 | $80 | $41 | $60.666 | $33.46 | 81.31% |
| 2023-08-15 | 15 | $80 | $41 | $60.5 | $33.46 | 80.81% |
| 2023-10-09 | 14 | $80 | $41 | $61 | $33.46 | 82.31% |
| 2023-10-19 | 14 | $80 | $41 | $61.4 | $33.46 | 83.5% |
| 2023-10-20 | 14 | $80 | $41 | $62 | $33.46 | 85.3% |
| 2023-11-06 | 14 | $80 | $41 | $61.6 | $33.46 | 84.1% |
| 2023-11-07 | 15 | $80 | $41 | $61.875 | $33.46 | 84.92% |
| 2023-12-04 | 16 | $80 | $41 | $61.176 | $33.46 | 82.83% |
The Trend in the Analyst Price Target
CYTK's average price target has moved down $0.76 over the prior 39 weeks.
CYTK reports an average of 68.83% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-03 | 15 | 80 | 48 | 61.933 | 41.95 | 47.64% |
| 2023-03-31 | 15 | 80 | 42 | 60.666 | 35.19 | 72.4% |
| 2023-04-03 | 15 | 80 | 42 | 60.533 | 37.71 | 60.52% |
| 2023-08-07 | 16 | 80 | 41 | 60.666 | 31.35 | 93.51% |
| 2023-11-03 | 14 | 80 | 41 | 61.600 | 36.32 | 69.6% |
CYTK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 13 | 2 | 1 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 45 months, CYTK's average broker recommendation rating worsened by 0.25.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CYTOKINETICS INC's upside potential (average analyst target price relative to current price) is greater than 4170.7% of all US stocks.
- CYTOKINETICS INC's number of analysts covering the stock is higher than 4890.15% of stocks in the mid market cap category.
- CYTK has a greater average analyst price target than 4281.54% of Pharmaceutical Products stocks.
- CYTK has a lower variance in analysts' estimates than -3785.84% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CYTOKINETICS INC are DVAX, TGTX, and OPK.
View All Top Stocks by Price Target
Is CYTK a Buy, Hold or Sell? See the POWR Ratings now!